The ‘top-notch’ London-based group at Mathys & Squire LLP is well-equipped to assist in matters spanning sectors from life sciences and chemistry to IT and tech. Its workload incorporates managing the portfolios of large corporations, start-ups, Universities, NGOs and more, as well as assisting with granting and filing, with IP strategising and with EPO opposition matters. Chemistry specialist Chris Hamer leads the offering alongside ’standout’ engineering expert Paul Cozens, Cambridge-based Alan MacDougall who has notable tech expertise, and Martin MacLean who manages portfolios for corporate and government bodies, in particular. The four co-lead the offering. Oliver Parish is noted for his ‘excellent technical knowledge’.
Legal 500 Editorial commentary

Accolades

Client satisfaction

Testimonials

Collated independently by Legal 500 research team.

  • ‘The Mathys team is easy and a joy to work with. They have the experience and requisite background to digest complex scientific matters and undertake well-done patent prosecution. I quite enjoy strategizing together and our collaborative efforts. They are pleasant and appropriate in communications, as well as responsive.’

  • ‘Dani Kramer is a pleasure to work with. He is sharp, provides excellent and cost-effective advice and professional services.’

  • ‘I work with the team around partner Sean Leach, who is exceptionally responsive and technically highly competent, as is his team. Pleasant to work with, always transparent, flexible - highly recommended.’

  • ‘Sean Leach is highly skilled technically, a great communicator, an excellent patent attorney, very experienced and very responsive.’

  • ‘Paul Cozens as a standout partner, and Oliver Parish has impressive technical knowledge.’

  • ‘Fantastic team work from an absolutely top-notch team.’

  • ‘Very skilled and knowledgeable.'

  • 'They are absolutely committed to working with the customer. James Pitchford is outstanding with his knowledge and ability to apply it to IP writing.’

  • 'They have exceptional experience and expertise.'

  • 'They are a go to firm for EPO consultation.'

Key clients

  • Ipsen Bioinnovation
  • DW Windsor
  • AAK AB
  • Modini Limited
  • Samphire Neuroscience Ltd
  • New England Biolabs, Inc. (“NEB”)
  • De’Longhi Deutschland GmbH
  • Novo Nordisk
  • Biogen MA Inc

Work highlights

Advised on the opposition of nine EP patents related to RNA vaccines for infectious diseases like influenza and coronavirus.
Represented the client in GPUs and AI across the EPO, UK, and Germany.
Represented DW Windsor in a successful patent infringement case against Schréder, involving two GB patents for anti-climb lighting units.

Practice head

Paul Cozens; Chris Hamer; Alan MacDougall; Martin MacLean

Other key lawyers

Andrea McShane; Dani Kramer; Sean Leach; Oliver Parish; James Pitchford; Philippa Griffin; James Wilding; Andrew White